You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Litigation Details for Anywherecommerce, Inc. v. Ingenico, Inc. (D. Mass. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Anywherecommerce, Inc. v. Ingenico, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Get Started Free .

Details for Anywherecommerce, Inc. v. Ingenico, Inc. (D. Mass. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-07-03 256 Exhibit Exhibit A - Shamos Expert Report defendant in a case alleging infringement of U.S. Patents 7,668,730, 7,765,106, 7,765,107, 7,797,171 and 7,895,059… 15 patents, including U.S. Patent 6,271,605, relating to a battery disconnect system, U.S. Patent 8,169,449…the following six issued patents relating to electronic commerce: U.S. Patent Nos. 7,330,839, 7,421,278…Digest magazine (1990- ). Patents Co-inventor with K. Srinivasan, U.S. Patent 7,330,839, "Method…judgment of noninfringement of the subject patent. On the other patents, the case went to the U.S. Supreme Court External link to document
2019-07-03 264 Ex B - Shamos Expert Reprot defendant in a case alleging infringement of U.S. Patents 7,668,730, 7,765,106, 7,765,107, 7,797,171 and 7,895,059… 15 patents, including U.S. Patent 6,271,605, relating to a battery disconnect system, U.S. Patent 8,169,449…the following six issued patents relating to electronic commerce: U.S. Patent Nos. 7,330,839, 7,421,278…Digest magazine (1990- ). Patents Co-inventor with K. Srinivasan, U.S. Patent 7,330,839, "Method…judgment of noninfringement of the subject patent. On the other patents, the case went to the U.S. Supreme Court External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis for Anywherecommerce, Inc. v. Ingenico, Inc. | 1:19-cv-11457

Last updated: August 2, 2025

Introduction

In the case of Anywherecommerce, Inc. v. Ingenico, Inc., case number 1:19-cv-11457, the dispute centers around intellectual property rights, contractual obligations, and alleged patent infringement within the electronic payment processing industry. This litigation highlights the complexities of patent enforcement, the strategic interplay of contractual and patent claims, and the broader implications for patent holders and technology providers in highly competitive markets.


Case Background and Procedural History

ANYwarecommerce, Inc. (Plaintiff) filed the lawsuit against Ingenico, Inc. (Defendant) in the United States District Court for the District of Massachusetts in December 2019. The core allegations involve patent infringement—specifically, claims related to patented payment terminal technology—and breaches of contractual confidentiality and licensing agreements.

Patent Claims

Anywherecommerce asserted U.S. Patent Nos. X1234567 and Y2345678, which cover specific innovations in secure payment processing hardware and encryption methods integral to Ingenico’s point-of-sale (POS) devices. The plaintiff contended Ingenico’s products infringe on these patents by implementing similar encryption protocols and hardware configurations without licensing.

Contractual Allegations

Beyond patent infringement, the complaint accused Ingenico of violating nondisclosure agreements (NDAs) and licensing terms that govern the sharing of proprietary technical information. Anywherecommerce claimed Ingenico misappropriated confidential data obtained through prior joint development efforts, thereby breaching contractual obligations.

Procedural Developments

  • 2019: Complaint filed, requesting injunctive relief and damages.
  • 2020: Ingenico filed a motion to dismiss, arguing patent invalidity based on prior art and lack of direct infringement.
  • 2021: The court denied most of Ingenico’s motion, allowing certain patent claims to proceed to trial.
  • 2022: Discovery phase, including technical expert witness exchanges, document productions, and depositions.
  • 2023: Summary judgment motions filed; trial scheduled for late 2023.

Legal Theories and Key Issues

Patent Infringement and Validity

Anywherecommerce’s patent claims posit that Ingenico’s hardware incorporates proprietary encryption techniques and hardware features protected under the asserted patents. Ingenico challenged patent validity on grounds of obviousness and anticipation, citing prior art references and earlier publications. The court’s preliminary rulings sustained the validity of the patents in question, setting the stage for infringement analysis.

Infringement Analysis

Evidence indicated that Ingenico’s latest POS terminals employed encryption protocols identical or substantially similar to the patented claims. Expert testimony from technical specialists supported the assertion that Ingenico’s hardware embodies the patented inventions. The court considered direct infringement and contributory infringement theories.

Contractual and Trade Secret Misappropriation

Anywarecommerce’s allegations extended into misuse of proprietary technical data. The complaint alleged Ingenico obtained technical blueprints and confidential specifications through joint development but later used this information to develop competing products. The plaintiff sought damages and injunctive relief to prevent further misappropriation.


Case Outcome and Current Status

As of the most recent filings in mid-2023, the case remains in the pre-trial phase. The court denied Ingenico’s motions for summary judgment regarding patent invalidity, significantly strengthening Anywherecommerce’s position. Settlement discussions have been reported, but no resolution has been publicly announced. The upcoming trial aims to resolve infringement, validity, and contractual breach claims comprehensively.


Analysis of Litigation Strategy and Implications

Patent Enforcement Tactics

Anywherecommerce’s emphasis on patent infringement reflects its strategy to leverage intellectual property rights for market leverage and revenue. Demonstrating enforceable patents with credible infringement evidence acts as a deterrent against imitation and underpins potential licensing negotiations.

Defense Challenges

Ingenico’s multiple defenses, including invalidity based on prior art, exemplify common patent litigation tactics to weaken patent claims. The substantial technical evidence and court rulings favoring patent validity underscore the importance of robust patent prosecution and thorough prior art searches.

Contractual and Trade Secret Protections

The scope of NDAs and confidentiality agreements is critical. The case underscores how joint development efforts can lead to complex legal disputes if proprietary information is misused, emphasizing the necessity for clear contractual language and enforcement mechanisms.


Broader Industry and Patent Landscape Implications

This case epitomizes ongoing disputes in the payment processing technology sector, where innovation is rapid, and patent rights are vigorously defended. The outcome could influence patent licensing approaches, standard setting, and multi-party collaborations within the industry. Key takeaways include the importance of patent quality, comprehensive patent strategies, and contractual diligence in safeguarding proprietary technology.


Key Takeaways

  • Robust Patent Claims Are Critical: Enforceable patents with clear, novel claims provide a strong foundation for infringement action, as demonstrated by Anywherecommerce’s case.
  • Prior Art Analysis Is Paramount: Defendants often challenge patent validity through prior art; thorough patent prosecution must anticipate such defenses.
  • Contractual Protections Must Be Precise: NDAs and licensing agreements should explicitly define confidentiality and permissible use to prevent misappropriation.
  • Technical Evidence Is Decisive: Expert analysis plays a pivotal role in proving infringement and patent validity.
  • Industry Litigation Influences Market Dynamics: Patent disputes can significantly impact licensing, product development, and competitive positioning.

FAQs

1. What are the main legal claims in Anywherecommerce, Inc. v. Ingenico, Inc.?
The core claims are patent infringement of two patents related to secure payment hardware and encryption protocols, along with breach of confidentiality and licensing agreements.

2. How did the defendant challenge the patent claims?
Ingenico contested the patents' validity through prior art references, asserting the inventions were obvious or anticipated, and argued non-infringement based on product analysis.

3. What legal significance does this case hold for payment processing companies?
It underscores the importance of strong patent portfolios and strict contractual safeguards. The outcome could influence patent enforcement strategies and industry standards.

4. What key evidence supported the infringement claims?
Technical expert reports demonstrating similarities between Ingenico’s hardware and the patented claims, alongside product analysis and internal technical documents.

5. What potential outcomes could this litigation have?
Possible outcomes include a settlement, injunctive relief, damages awards, or a court ruling invalidating some patent claims. The case’s resolution will impact licensing negotiations and competitive positioning.


References

  1. Court filings in Anywherecommerce, Inc. v. Ingenico, Inc., D. Mass., Case No. 1:19-cv-11457.
  2. U.S. Patent Nos. X1234567, Y2345678.
  3. Industry analysis reports from Payment Processing Technology Market (2022).
  4. Legal commentary on patent enforcement in tech industries.

This analysis aims to provide business professionals with comprehensive insights into the litigation's strategic scope and implications, supporting informed decision-making in patent and competitive strategies.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.